Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
Pharmaceuticals · 22.01.2023 · 16 (2) · 160
DOI: 10.3390/ph16020160 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.01.2023. Verfasst von Suneel Kumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Design Innovation Centre, Rani Durgavati University, Jabalpur 482 001, India. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Cancer represents the second most deadly disease and one of the most important public health concerns worldwide. Surgery, chemotherapy, radiation therapy, and immune therapy are the major types of treatment strategies that have been implemented in cancer treatment. Unfortunately, these treatment options suffer from major limitations, such as drug-resistance and adverse effects, which may eventually result in disease recurrence. Many phytochemicals have been investigated for their antitumor efficacy in preclinical models and clinical studies to discover newer therapeutic agents with fewer adverse effects. Withaferin A, a natural bioactive molecule isolated from the Indian medicinal plant Withania somnifera (L.) Dunal, has been reported to impart anticancer activities against various cancer cell lines and preclinical cancer models by modulating the expression and activity of different oncogenic proteins. In this article, we have comprehensively discussed the biosynthesis of withaferin A as well as its antineoplastic activities and mode-of-action in in vitro and in vivo settings. We have also reviewed the effect of withaferin A on the expression of miRNAs, its combinational effect with other cytotoxic agents, withaferin A-based formulations, safety and toxicity profiles, and its clinical potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bio-Design Innovation Centre, Rani Durgavati University, Jabalpur 482 001, India.
- Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
- Department of Botany, Government College Kurai, Seoni 480 880, India.
- Department of Biotechnology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala 133 207, India.
- Department of Studies in Molecular Biology, University of Mysore, Mysuru 570 006, India.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
ORCID-Profile: Stephen O Mathew, Ravindra Prasad Aharwal, Hardeep Singh Tulli, Kwang-Seok Ahn, Anupam Bishayee
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kumar, S., Mathew, S. O., Aharwal, R. P., Tulli, H. S., Mohan, C. D., Sethi, G., Ahn, K. S., Webber, K., Sandhu, S. S., & Bishayee, A. (2023). Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal. Pharmaceuticals, 16(2), 160. https://doi.org/10.3390/ph16020160
Vancouver
Kumar S, Mathew SO, Aharwal RP, Tulli HS, Mohan CD, Sethi G, et al. Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal. Pharmaceuticals. 2023;16(2):160. doi:10.3390/ph16020160
BibTeX
@article{Kumar2023,
author = {Kumar, Suneel and Mathew, Stephen O and Aharwal, Ravindra Prasad and Tulli, Hardeep Singh and Mohan, Chakrabhavi Dhananjaya and Sethi, Gautam and Ahn, Kwang-Seok and Webber, Kassidy and Sandhu, Sardul Singh and Bishayee, Anupam},
title = {Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {2},
pages = {160},
doi = {10.3390/ph16020160}
}
EUVIMED